On Friday, the industry ushered in heavy policies as usual. And this time, the SARS-CoV-2 Antigen Rapid Test(colloidal gold), which has been wildly grabbed around the world, will finally detonate the domestic market.
On March 11, the official website of the National Health and Medical Commission issued the "Notice on Printing and Distributing the New Coronavirus Antigen Detection Application Plan (Trial)" (hereinafter referred to as the "Application Plan"), and the supporting "Basic Operational Procedures for New Coronavirus Antigen Detection in Primary Medical and Health Institutions" "(hereinafter referred to as "Operational Procedures for Primary Medical Institutions", "Basic Requirements and Procedures for Self-Testing of New Coronavirus Antigens"
The "Application Plan" pointed out that antigen detection should be added on the basis of nucleic acid detection as a supplement. Community residents who have self-test needs can purchase antigen test reagents for self-test through retail pharmacies, online sales platforms and other channels. This means that the rapid test for the new crown antigen, which is popular all over the world, will be officially allowed to be used in China and provide a key basis for home testing.
Since the second half of 2021, the number of people infected with the new coronavirus has grown rapidly around the world, and the fast and convenient 2019-nCoV Antigen Rapid Test(colloidal gold) has become almost the most sought-after medical item. In the United States, South Korea, Japan and other places, the new crown antigen rapid detection kit is almost Sold out as soon as it was released.
Therefore, when the news that the domestic new crown testing is about to be released in China appeared, the enthusiasm of the market was instantly ignited.
The article comes from Arterial Network, author Wang Shiwei
Post time: Mar-23-2022